3[2]Boehm S, Schlenk EA, Raleigh E, et al. Behavior alanalysis and behavioral strategies to improve self- management to type Ⅱ diabetes[J ].Clin Nurs Res, 1993,3: 327.
4亚太地区糖尿病政策组.2型糖尿病实用目标与治疗[J].中国糖尿病杂志,2000,(8):60.
5Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care,1997, 20:1664.
6Jia WP, Xiang KS, Chen L, et al. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev,2002, 3:157.
7Xu Z, Wang Y, Jing H, et al. Uncontrolled diabetes and cluster of macrovascular risk factors-severe challenge in health care in China.Diabetes Metab,2003, 29:4S10.
8Colquitt JL, Green C, Sidhu MK, et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes, Health Technology Assessment 2004;8:43.
9Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26:1079 - 1087.
10Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials, BMJ 2002; 324: 705.
